These findings demonstrate that CRC progression is driven by functional heterogeneity among malignant cells, their spatially organized molecular gene expression upregulation (TMSB4X in tumor cells), regional activation of key oncogenic pathways and active signaling crosstalk between tumor and stromal compartments. Here, TMSB4X is linked to neoplasm.